Recommended Reading on Myocardial and Pericardial Diseases
ESC Working Group on Myocardial and Pericardial Diseases
-
21/04/2025
-
21/04/2025
-
01/04/2023
-
01/04/2023
-
01/04/2023
-
01/04/2022
-
01/04/2022
-
01/04/2022
-
14/12/2021
-
01/12/2021
-
01/12/2021
-
01/10/2021
-
08/09/2021
-
04/08/2021
-
17/07/2021
-
07/07/2021
-
29/05/2021
-
07/05/2021
-
03/03/2021
-
03/03/2021
-
25/02/2021
-
22/02/2021
-
01/01/2021
-
12/11/2020
-
11/11/2020
-
01/11/2020
-
12/10/2020
-
29/09/2020
-
15/09/2020
-
01/09/2020
-
15/07/2020
-
01/06/2020
-
21/01/2020
-
10/01/2020
-
01/01/2020
-
01/01/2020
-
13/11/2019
-
07/11/2019
-
05/11/2019
-
01/10/2019
-
18/09/2019
-
04/09/2019
-
01/09/2019
-
22/08/2019
-
17/08/2019
-
02/07/2019
-
02/07/2019
-
24/05/2019
-
24/05/2019
-
24/05/2019
-
13/03/2019
-
11/03/2019
-
22/02/2019
-
10/01/2019
-
01/01/2019
-
21/11/2018
-
13/11/2018
-
01/11/2018
-
15/10/2018
-
11/10/2018
-
01/10/2018
-
01/10/2018
-
14/09/2018
-
13/09/2018
-
07/08/2018
-
02/07/2018
The role of cardiovascular multimodality imaging in the evaluation of Anderson–Fabry disease: from early diagnosis to therapy monitoring A clinical consensus statement of the ESC Working Group on Myocardial and Pericardial Diseases and the European Association of Cardiovascular Imaging of the ESC
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists<sup> </sup>
Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis
Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries